{
    "2021-02-19": [
        [
            {
                "time": "",
                "original_text": "抗体偶联药物进入爆发期，恒瑞、荣昌生物、高瓴等抢占百亿市场",
                "features": {
                    "keywords": [
                        "抗体偶联药物",
                        "恒瑞",
                        "荣昌生物",
                        "高瓴",
                        "百亿市场"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "抱团股震荡，拒绝抱团但业绩出色的基金名单来了！",
                "features": {
                    "keywords": [
                        "抱团股",
                        "震荡",
                        "基金",
                        "业绩出色"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "盘后公告集锦|温氏股份2020年净利润同比减少47%",
                "features": {
                    "keywords": [
                        "温氏股份",
                        "净利润",
                        "同比减少",
                        "47%"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "竞争“小癌种”市场，国产PD-1单抗获批治疗晚期鼻咽癌",
                "features": {
                    "keywords": [
                        "小癌种",
                        "国产PD-1单抗",
                        "晚期鼻咽癌",
                        "获批"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-02-19",
                "original_text": "晚间重要公告2021年2月19日星期五",
                "features": {
                    "keywords": [
                        "晚间公告",
                        "2021-02-19"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：两款抗癌药物获得药物临床试验批准通知书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "抗癌药物",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药（600276.SH）：氟唑帕利胶囊及甲磺酸阿帕替尼片获批临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "氟唑帕利胶囊",
                        "甲磺酸阿帕替尼片",
                        "临床试验",
                        "获批"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "艾德生物（300685）：Q4业绩加速增长 看好长期成长性",
                "features": {
                    "keywords": [
                        "艾德生物",
                        "Q4业绩",
                        "加速增长",
                        "长期成长性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-02-18",
                "original_text": "A股融资融券日报：两融余额增加250.86亿元（2月18日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加",
                        "250.86亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场资金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗板块惨绿中欧医疗跌上热搜 网友：过年前卖得太及时了",
                "features": {
                    "keywords": [
                        "医疗板块",
                        "惨绿",
                        "中欧医疗",
                        "跌上热搜"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-19",
                "original_text": "晨报0219 | 医药春季策略、新式茶饮行业专题、盘江股份（600395）",
                "features": {
                    "keywords": [
                        "医药春季策略",
                        "新式茶饮",
                        "盘江股份"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}